Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.23.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.466.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.75.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBHNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BL.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.78NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.9.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.64NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.221.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DP.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BL.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.62NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.82NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.38.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.79.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.47NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.55NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BY.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EA.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XJNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BR.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.29NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.8.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FC.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BY.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.123 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.27NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.71NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.12.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DN.1.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.51NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XRNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.350.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.254NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39.1.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.418NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.9.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used